• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Antiemetic Guidelines for Chemotherapy and Radiation Therapy
Antiemetic Guidelines for Chemotherapy and Radiation Therapy

... The literature supports the use of 5HT3 BEFORE chemotherapy and radiotherapy as a first line prophylactic antiemetic. The data shows that 5HT3 are ineffective when given more than 24h after chemotherapy. The side effects of constipation and headache are also additive in patients who have these side ...
product monograph vaniqa
product monograph vaniqa

... treatment with eflornithine HCI significantly inhibited the growth of facial hair. Patients were treated with either eflornithine (N = 395) or vehicle (N = 201) twice daily for a duration of 24 weeks, in each of these studies. Physician's Global Assessment (PGA) evaluated the improvement or worsenin ...
Pharmacogenetics and Determining Warfarin Dosage
Pharmacogenetics and Determining Warfarin Dosage

... doctors.    Several  clinical  trials  have  been  conducted  in  the  last  few  years  to  examine  the   difference  between  pharmacogenetically-­‐guided  dosing  and  standard  clinical  dosing.     These  trials  have  had  mixed  res ...
Fading Sugammadex, or Just Cautiously (re) Considered?!
Fading Sugammadex, or Just Cautiously (re) Considered?!

... A subgroup analysis in an enlarged sugammadex group – TIVA with remifentanyl versus TIVA with fentanyl - might have beheaded some of these speculations of a naïve mind such as mine. A possible explanation for the lack of difference between the 2 groups compared is due to the fact that in small doses ...
Design and Evaluation of Niosomal Gel Delivery Systems for Topical
Design and Evaluation of Niosomal Gel Delivery Systems for Topical

... bioavailability. Niosomes seem an interesting drug delivery system in the treatment of dermatological disorders. In fact, topically applied niosomes can increase the residence time of drugs in the stratum corneum and epidermis, while reducing the systemic absorption of the drug. Niosomes have also b ...
Pain control and controlled drug prescribing
Pain control and controlled drug prescribing

... The patient is stabilised on diamorphine 90mg/24hrs after titration of the dose. Convert back to a fentanyl patch. What issues do you need to consider? ...
5 points
5 points

... Drug X is given as i.v bolus of 200 mg (TID) dose. The concentration-time profile for the first three doses is shown. This patient has a clearance of 24L/hr (top graph). Another patient came in and was started on the same dosing regimen. However, this patient had a clearance 6 L/hr. What would his c ...
ISOA/ARF Drug Development Tutorial
ISOA/ARF Drug Development Tutorial

... disease process, and that modulation of the target is likely to have a therapeutic effect. ...
general principles of pharmacology
general principles of pharmacology

... GENERAL PRINCIPLES OF PHARMACOLOGY ...
the file - General Practice
the file - General Practice

... 1. Prescribing should only be initiated where there is clear evidence of dependency from the history and urine toxicology. (Caution clients may exaggerate the amount they are taking). This will be in conjunction with a full comprehensive assessment via the substance misuse service. 2. In general, it ...
Review of Basic Reference (1) Section
Review of Basic Reference (1) Section

... Published annually. Monthly Updates Online http://uspdi.micromedex.com/ ...
Elimination
Elimination

... Saliva volume is typically one to two liters per day with flow rates ranging from 0.5 ml/min to more than 10 times that in the presence or thought of food. Saliva pH commonly ranges between 7.4 and 6.2 although lower values are possible. Saliva also contains a number of enzymes including amylase, pt ...
Real-Time Cell-Based Toxicology Testing Might Replace Animal
Real-Time Cell-Based Toxicology Testing Might Replace Animal

... of drug candidates. Currently, laboratory animals are required to be used in the release of pharmaceutical products such as botulinum toxin type A and in the prediction of cardio­toxicity of new drugs. Such tests consume very large numbers of laboratory animals. We believe that the xCELLigence Syste ...
A short introduction to pharmacokinetics
A short introduction to pharmacokinetics

... a pharmacokinetic study is often huge. As an example, in a typical study of bioequivalence in man, there are generally not less than 12 plasma samples in at least 18 subjects treated with two formulations of the same drug. The consequence is that not less than 12 × 18 × 2 = 432 set of data (time, pl ...
Cathflo Activase 1 (Alteplase)
Cathflo Activase 1 (Alteplase)

... similar to that observed in Trial 2, as were the rates of function restoration ...
INTRODUCTION TO ANAESTHETIC DRUGS DRUGS
INTRODUCTION TO ANAESTHETIC DRUGS DRUGS

... away once muscle relaxant working ). If available etomidate is a reasonable drug to use. When intubating these children you need to have IV fluids and vasopressor and/or inotrope immediately available because any induction agent plus positive pressure ventilation can precipitate CVS collapse. Rememb ...
Opioid conversion tips Changing to another oral opioid
Opioid conversion tips Changing to another oral opioid

... When is it addiction? How can you tell if your patient is truly addicted to opioids? The following definitions are jointly from The American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine: Addiction: Addiction is a primary, chronic, neurobiologic ...
Metform
Metform

... renal function. It should be temporarily discontinued in patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials, because use of such products may result in acute alteration of renal function. Drug Interactions Plasma concentration of Metformin i ...
T Thalidomide
T Thalidomide

... after the first and third months after treatment initiation with thalidomide, then every 3 months thereafter, as HIV mRNA levels may be increased while on thalidomide. Instruct patients to avoid operating heavy machinery or driving a car while on thalidomide as the drug can cause drowsiness. Patient ...
Implications of TG-43 for Dose Prescription and Calculations for I
Implications of TG-43 for Dose Prescription and Calculations for I

... developed and is prepared to adopt a new calibration standard for 125I seeds. The current standard, established in 1985, is now known to be contaminated by non-penetrating low energy photons (4.5 keV titanium x-rays, which penetrate only about 0.1 mm in tissue). The change in calibration will reduce ...
a review of pharmacological and pharmaceutical profile of irbesartan
a review of pharmacological and pharmaceutical profile of irbesartan

... blood pressure regardless of patient age, gender or race. However, the effect in black patients, typically a low renin population, is somewhat lower. In comparative trials irbesartan was shown to be at least as effective as hydrochlorothiazide, atenolol and the full dosage of enalapril. And in combi ...
BioInvent Interim Report 1 January – 30 June 2015
BioInvent Interim Report 1 January – 30 June 2015

... BioInvent’s preclinical research is aimed at expanding the Company’s portfolio of drug candidates. Since 2012 the Company has focused its own research resources entirely on cancer. Over the past decade the Company has accumulated a significant body of experience of relevant disease models within can ...
Opioid Substition Therapy - California Opioid Maintenance Providers
Opioid Substition Therapy - California Opioid Maintenance Providers

... impact on MMT staff; providing support  regular assessment of staff attitudes and ...
“taking the mystery out of oral medications”
“taking the mystery out of oral medications”

... • An alternative approach is to give twice the desired dose every other day then don’t taper. Only for short term use • Theory is that anti-inflammatory properties remain high but suppression of HPA axis is much, much less • For long term use taper must be very slow • As OD’s we rarely would be invo ...
BECOTIDE™/ BECLOFORTE™ INHALER GlaxoSmithKline
BECOTIDE™/ BECLOFORTE™ INHALER GlaxoSmithKline

... in children and adolescents, decrease in bone mineral density, cataract and glaucoma. It is important, therefore, that the dose of inhaled corticosteroid is titrated to the lowest dose at which effective control is maintained (see Adverse Reactions). It is recommended that the height of children rec ...
< 1 ... 328 329 330 331 332 333 334 335 336 ... 532 >

Theralizumab

  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report